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Abstract: Fluorescence in situ hybridization using peptide nucleic acid probes (PNA-FISH) 
differentiates Staphylococcus aureus from other Gram-positive-cocci in clusters (GPCC). 
101/202 patients with GPCC+ blood cultures were randomly assigned to clinician-notiﬁ  cation 
of PNA FISH results. Notiﬁ  cation was associated with reduced mortality (8% vs.17%, 
p = 0.05), further antibiotic use (median −2.5 days, p = 0.01), and trended toward reduced 
hospital stay and charges.
Introduction
Optimization of antimicrobial therapy in patients with positive blood cultures remains 
a major challenge. Among hospitalized patients staphylococci are the most frequent 
bloodstream isolates. Coagulase-negative staphylococci (CoNS) are commonly iso-
lated from blood, but only ∼20% of such cultures represent true infection, the rest 
being contaminants (Beekmann et al 2005). True CoNS infections are nearly always 
associated with foreign bodies, particularly vascular catheters and implantable medical 
devices. Conversely, blood cultures growing Staphylococcus aureus signify bacte-
remia requiring prompt antibiotic administration and are associated with signiﬁ  cant 
morbidity and mortality. Appropriate use of antibiotics in these settings may improve 
clinical outcomes, reduce exposure to unnecessary antibiotics, and decrease length-
of-hospitalization and healthcare costs (Dunagan et al 1989).
Furthermore, rapid detection of bloodstream infections and delivery of that informa-
tion to treating clinicians facilitates optimization of antimicrobial therapy and focused 
use of healthcare resources (Beekmann et al 2003). Peptide nucleic acid ﬂ  uorescence 
in situ hybridization (PNA FISHTM; AdvanDx, Woburn, MA) differentiates S. aureus 
from CoNS by targeting the 16S rRNA of S. aureus (Oliveira et al 2002). The test 
can be performed in 3.5 hours or less and identiﬁ  es S. aureus directly from blood 
cultures with a sensitivity and speciﬁ  city exceeding 98% (Oliveira et al 2003). Use of 
PNA FISH for differentiation between S. aureus and CoNS has been shown to reduce 
antimicrobial usage and hospital length-of-stay by two days (Forrest et al 2006). PNA 
FISH has been routinely used in the microbiology laboratory at our institution since 
2005. We hypothesized that the addition of a liaison that promptly relays results from 
the microbiology department to the provider will further improve patient outcomes 
and utilization of healthcare resources.
Current practice patterns at our hospital are such that there is a direct communica-
tion between the laboratory and the clinician with positive gram stains from blood 
cultures. “Gram-positive cocci in clusters” (GPCC) are relayed to the clinician from 
the laboratory. However, there is no direct communication between the laboratory and Therapeutics and Clinical Risk Management 2008:4(3) 638
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healthcare provider with regards to PNA FISH results once 
they are available (identiﬁ  cation of the GPCC as “S. aureus 
or coagulase-negative staphylococcus”). Clinicians are obli-
gated to follow up with results whenever their time permits 
and base their decisions accordingly. We propose that an 
important aspect of a successful early detection program 
is providing a liaison that can promptly relay results from 
the microbiology department to the provider and encourage 
proper therapy, quickly and efﬁ  ciently. This intervention 
will likely lead to a decrease in antibiotic misuse, decrease 
overall hospital costs, and length-of-stay.
To test this hypothesis, we conducted a prospective, 
randomized controlled study to evaluate whether presence 
of a liaison that rapidly relays results from laboratory to 
physicians has any effect on length-of-hospital stay, hospital 
costs, and antibiotic use.
Methods
Washington Hospital Center (WHC) is a 907-bed tertiary 
care medical facility in Washington DC. This hospital’s 
institutional review board approved this study. This was a 
prospective, randomized, controlled study performed from 
March 22, 2006 to October 31, 2006.
PNA FISH was performed twice daily on all blood cultures 
positive for GPCC. Results were entered into the hospital’s 
laboratory information system and a list with the results was 
faxed twice daily to a laboratory/clinician liaison (LCL). 
Patients were blindly randomized 1:1, regardless of location 
within the hospital, to intervention or usual care by alternately 
assigning patients from the list to each group. Patients whose 
blood cultures were repeatedly positive for GPCC were only 
counted once. Patients were excluded if they were younger than 
18 years of age, outpatients, or expired prior to the availability 
of microbiology results. The intervention consisted of notify-
ing the treating clinician of the results and providing general 
information about the organism isolated within three hours of 
the test’s performance. Patients were further classiﬁ  ed accord-
ing to their location within the hospital at enrollment.
Medical records of enrolled patients were abstracted for 
demographics, comorbid conditions, location within the 
hospital, antimicrobial use, length of hospitalization, transfer 
to intensive care unit (ICU), and mortality.
All baseline patient characteristics were compared by 
chi-square test except for age and the Charleson Index, which 
were compared using the t-test. The medians for the outcome 
variables in the intervention and usual care groups were com-
pared using Wilcoxon rank sum test. Statistical analyses were 
performed using STATA 9.1 (College station, Texas).
Results
Two hundred and twenty six patients with blood cultures 
positive for GPCC were screened. 24 patients were excluded, 
as they did not meet the inclusion criteria. 202 patients were 
included in the study and treating clinicians were contacted 
in 101 of those (intervention). CoNS and S. aureus were 
identiﬁ  ed in 141 and 61 patients, respectively. Among those 
with CoNS, 72 patients were assigned to the control arm and 
69, to intervention. In those with S. aureus 29 were assigned 
to the control arm and 32, to intervention.
Overall baseline characteristics including demograph-
ics, central venous catheters, presence of central line, and 
concomitant infections were similar in all groups. The mean 
Charleson comorbidity index was 3 and 5 for all groups, 
but was higher in the usual care vs. intervention group for 
patients with CoNS (4.49 vs.3.71, p = 0.048).
Rates of mortality, median lengths of hospitalization, and 
antimicrobial use following enrollment and median total hos-
pital charges are shown in Table 1 for intervention and usual-
care groups. Use of the laboratory clinical liaison resulted in 
reduced overall mortality (16.8% vs. 7.9%; p = 0.05). The 
biggest impact was seen among patients in the intensive care 
unit (47.8% vs.9.5%; p = 0.01). Use of the laboratory clinical 
liaison resulted in a reduction in overall further antimicrobial 
use (−2.0 days, p = 0.01) and antimicrobial use in patients 
with blood cultures showing CoNS (−2.5 days, p = 0.01) 
regardless of location within the hospital. Early notiﬁ  cation 
was associated with a trend toward reduced median hospital 
charges (−$19,441.37, p=0.09) and for patients with CoNS a 
decreased subsequent length of hospitalization (−2 days for 
all patients and −7 days for ICU patients). Rates of transfer 
to ICU and utilization of echocardiography were similar in 
both the intervention and usual care groups.
Discussion
Rapid differentiation of S. aureus from CoNS in blood culture 
using PNA FISH facilitates focused use of healthcare resources 
(Forrest et al 2006). However, the clinical impact of rapid 
diagnostic tests is dependent on expeditious delivery of data 
to the treating clinician (Doern 1986; Beekmann et al 2003). 
In patients with bloodstream infections most therapy interven-
tions occur at the time of phlebotomy and after notiﬁ  cation of 
Gram stain results by telephone (Munson et al 2003). In this 
study we demonstrate that combining a rapid diagnostic test 
(PNA FISH) with prompt and direct communication of micro-
biological results is associated with improved outcomes.
Use of the laboratory clinical liaison resulted in 
reduced overall mortality (16.8% vs. 7.9%; p = 0.05). This Therapeutics and Clinical Risk Management 2008:4(3) 639
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was particularly noticeable in the ICU (47.8% vs.9.5%; 
p = 0.01). Critically ill patients may not tolerate delays 
in therapy of active bloodstream infections. Receipt of 
inadequate antimicrobial therapy has been correlated with 
increased hospital mortality for infected critically ill patients 
(Kollef et al 1999). We speculate that the reduced mortality 
associated with our intervention arm was related to early 
communication with ICU clinicians leading to improved 
antimicrobial use.
Communication with the treating clinician resulted in a 
signiﬁ  cant reduction in further antimicrobial use overall. This 
was driven by the signiﬁ  cant reduction in antibiotic utiliza-
tion among patients with CoNS (−2.5 days, p = 0.01). Since 
only a minority of cases with CoNS positive blood cultures 
represents true bacteremia, early access to microbiological 
data identifying the blood culture organism as CoNS likely 
encouraged clinicians to limit further antimicrobial therapy 
in most of those patients.
False-positive blood cultures have been associated 
with increased subsequent length of stay and hospital 
charges (Bates et al 1991). In our patients with CoNS, the 
intervention was associated with a decreased subsequent 
length of hospitalization, however, this did not reach 
statistical signiﬁ  cance. Early notiﬁ  cation was associated 
with a trend toward reduced median hospital charges 
(−$19,441.37, p = 0.09). This is consistent with observations 
suggesting that time-to-notiﬁ  cation signiﬁ  cantly impacts 
hospital charges in bacteremia (Beekmann et al 2003). 
Enhanced communication of between the laboratory 
and clinicians likely facilitated more rapid utilization of 
focused therapy.
Baseline comorbidities were compared using the Charlson 
comorbidity index, a weighted score that takes into account 
the number and the seriousness of comorbid diseases. One-
year mortality has been reported as 52% for patients with 
score of 3–4 and 85% with a score of 5 or more (Charlson 
et al 1987). Mean index scores for all groups in our study 
were 3 and 5. A possible confounder for our study was 
a higher mean index for control patients with CoNS com-
pared with the intervention group (4.49 vs.3.71, p = 0.048). 
An index of 3 predicts higher mortality for patients with 
S. aureus bacteremia (Lesens et al 2003). We do not know 
whether a difference in Charlson index above this threshold 
impacts the outcomes of hospitalized patients with CoNS 
bacteremia and pseudobacteremia.
In conclusion, this study suggests that in a clinical sce-
nario where rapid access to laboratory data can signiﬁ  cantly 
alter the course of treatment, delivery of that data via a 
laboratory clinician liaison can improve clinical outcomes 
and utilization of resources.
Table 1 Outcome variables by organism and location within the hospital: Length of stay and antibiotic use calculated from time of 
enrollment to hospital discharge. Charges are inclusive of entire hospitalization in United States dollars
All hospital locations All patients CoNS S. aureus
Usual care Notiﬁ  cation P Usual care Notiﬁ  cation P Usual care Notiﬁ  cation P
(N = 101) (N = 101) (N = 72) (N = 69) (N = 29) (N = 32)
Hospital stay, median days 9 9 9 7 0.23 14 15 0.67
Charges, median $ 92,373.78 72,932.41 0.09 65,900.23 64,368.66 0.12 110,198.4 103,973.6 0.23
Antibiotics, median day 3 1 0.01 2.5 0 0.01 9 9
Deaths, No (%) 17 (16.8) 8 (7.9) 0.05 11 (15.3) 5 (7.2) 0.133 6 (20.7) 3 (9.4) 0.213
Intensive care unit (N = 23) (N = 21) (N = 14) (N = 11) (N = 9) (10)
Hospital stay, median days 18 20 0.56 18 11 0.83 10.5 21.5 0.62
Stay, excluding deaths, 
median days
20 21 0.82 18.5 13.5 0.93 61.5 22 0.22
Charges, median $ 245,173 143,631 0.32 308,812 195,402 0.38 233,916 142,154 0.87
Antibiotics, median day 5 2 0.26 5 0 0.02 10 10
Deaths, No (%) 11 (47.8) 2 (9.5) 0.01 6 (42.9) 1 (9.1) 0.06 5 (55.6) 1 (10) 0.03
Nonintensive care unit (N = 78) (N = 80) (N = 58) (N = 58) (N = 20) (N = 22)
Hospital stay, median days 9 8 0.3 8 6.5 0.26 14 11 0.50
Charges, median $ 67,296 50,507 0.08 52,115 40,286 0.15 110,058 60,447 0.09
Antibiotics, median day 3 1 0.02 2 0 0.05 8.5 3.5 0.08
Deaths, No (%) 6 (7.7) 6 (7.5) 5 (8.7) 4 (6.9) 0.729 1 (5) 2 (9.1) 0.607Therapeutics and Clinical Risk Management 2008:4(3) 640
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